Effects of n-3 polyunsaturated fatty acids on depressive symptoms, anxiety and emotional state in patients with acute myocardial infarction

Pharmacological Reports

Volumn 65, Issue 1, 2013, Pages 59-68

  Haberka, Maciej ^a   Mizia Stec, Katarzyna ^a   Mizia, Magdalena ^a   Gieszczyk, Klaudia ^a   Chmiel, Artur ^a   Sitnik Warchulska, Katarzyna ^a   Ga̧sior, Zbigniew ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Acute myocardial infarction; Anxiety; Depression; Emotional state; Polyunsaturated fatty acids

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; OMEGA 3 ACID ETHYL ESTER; TROPONIN;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; ANXIETY DISORDER; ARTICLE; BECK DEPRESSION INVENTORY; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; EMOTIONAL DISORDER; EMOTIONAL STATE QUESTIONNAIRE; FEMALE; HEART EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PROSPECTIVE STUDY; PSYCHOLOGIC TEST; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; STATE TRAIT ANXIETY INVENTORY; SUPPLEMENTATION;

EID: 84875775482     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(13)70964-2     Document Type: Article

References (43)

1. Amin AA, Menon RA, Reid KJ, Harris WS, Spertus JA: Acute coronary syndrome patients with depression have low blood cell membrane omega-3 fatty acid levels. Psychosom Med, 2008, 70, 856-862.
2. Appleton KM, Hayward RC, Gunnell D, Peters TJ, Rogers PJ, Kessler D, Ness AR: Effects of n-3 longchain polyunsaturated fatty acids on depressed mood: systematic review of published trials. Am J Clin Nutr, 2006, 84, 1308-1316.
3. Appleton KM, Rogers PJ, Ness AR: Updated systematic review and metaanalysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am J Clin Nutr, 2010, 91, 757-770.
4. Barth J, Schumacher M, Herrmann-Lingen C: Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med, 2004, 66, 802-813.
5. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry, 1961, 4, 561-571.
6. Bruinsma KA, Taren DL: Dieting, essential fatty acid intake, and depression. Nutr Rev, 2000, 58, 98-108.
7. Carney RM, Freedland KE, Rubin EH, Rich MW, Steinmeyer BC, Harris WS: Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease. JAMA, 2009, 302, 1651-1657.
8. Cooper DC,MilicMS, Tafur JR,Mills PJ, BardwellWA, ZieglerMG, Dimsdale JE: Adverse impact ofmood on flow-mediated dilation. PsychosomMed, 2010, 72, 122-127.
9. Frasure-Smith N, Lesperance F, Julien P: Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes. Biol Psychiatry, 2004, 55, 891-896.
10. Glassman AH, Bigger JT, Gaffney M, Van Zyl LT: Heart rate variability in acute coronary syndrome patients withmajor depression. Arch Gen Psychiatry, 2007, 64, 1025-1031.
11. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R: European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehabil, 2007, 14, E1-40.
12. Green LA, Dickinson WP, Nease DE, Schellbase KG, Campos-Outcalt D, Schoof BK, Jeffcott-Pera M: AAFP guidelines for the detection and management of postmyocardial infarction depression. Ann Fam Med, 2009, 7, 71-79.
13. Grewal K, Stewart DE, Abbey SE, Leung YW, Irvine J, Grace SL: Timing of depressive symptom onset and inhospital complications among acute coronary syndrome inpatients. Psychosomatics, 2010, 51, 283-288.
14. Haag M: Essential fatty acids and the brain. Can J Psychiatry, 2003, 48, 195-203.
15. Haberka M, Mizia-Stec K, Mizia M, Janowska J, Gieszczyk K, Chmiel A, Zahorska-Markiewicz B, Ga̧sior Z: N-3 polyunsaturated fatty acids early supplementation improves ultrasound indices of endothelial function, but not through NO inhibitors in patients with acute myocardial infarction. N-3 PUFA supplementation in acute myocardial infarction. Clin Nutr, 2011, 30, 79-85.
16. Hibbeln JR: Fish consumption and major depression. Lancet, 1998, 351, 1213-1216.
17. Hibbeln JR, Salem N Jr: Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr, 1995, 62, 1-9.
18. Huffman JC, Stern TA: Neuropsychiatric consequences of cardiovascular medications. Dialogues Clin Neurosci, 2007, 9, 29-45.
19. Kiecolt-Glaser JK, Belury MA, Porter K, Beversdorf DQ, Lemeshow S, Glaser R: Depressive symptoms, omega-6:omega-3 fatty acids, and inflammation in older adults. Psychosom Med, 2007, 69, 217-224.
20. Kronish IM, Rieckmann N, Schwartz JE, Schwartz DR, Davidson KW: Is depression after an acute coronary syndrome simple a marker of known prognostic factors for mortality? Psychosom Med, 2009, 71, 697-703.
21. Kvaal K, Ulstein I, Nordhus IH, Engedal K: The Spielberger state-trait anxiety inventory (STAI): The state scale in detecting mental disorders in geriatric patients. Int J Geriatr Psychiatry, 2005, 20, 629-634.
22. Lichtman JH, Bigger JT, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lesperance F, Mark DB et al.: Depression and coronary heart disease: Recommendations for screening, referral, and treatment. Circulation, 2008, 118, 1768-1775.
23. Logan AC: Neurobehavioural aspects of omega-3 fatty acids: possible mechanisms and therapeutic value in major depression. Altern Med Rev, 2003, 8, 410-425.
24. Lucas M, Kirmayer LJ, Déry S, Dewailly E: Erythrocyte n-3 is inversely correlated with serious psychological distress among the Inuit: Data from the Nunavik Health Survey. J Am Coll Nutr, 2010, 29, 211-221.
25. Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, Franzosi MG et al.: Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation, 2002, 105, 1897-1903.
26. Mizia-Stec K, Haberka M, Mizia M, Janowska J, Chmiel A, Gieszczyk K, Zahorska-Markiewicz B, Ga̧sior Z: N-3 Polyunsaturated Fatty Acids therapy improves endothelial function, but does not affect adiponectin and resistin serum levels in the first month after myocardial infarction. Arch Med Sci, 2011, 7, 788-795.
27. Moser DK: "The rust of life": impact of anxiety on cardiac patients. Am J Crit Care, 2007, 16, 361-369.
28. Mozaffarian D, Rimm EB: Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA, 2006, 296, 1885-1899.
29. Nemets B, Stahl Z, Belmaker RH: Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry, 2002, 159, 477-479.
30. Ness AR, Gallacher JEJ, Bennett PD, Gunnell DJ, Rogers PJ, Kessler D, Burr ML: Advice to eat fish and mood: a randomized controlled trial in men with angina. Nutr Neurosci, 2003, 6, 63-65.
31. Parker GB, Heruc GA, Hilton TM, Olley A, Brotchie H, Hadzi-Pavlovic D, Friend C et al.: Low levels of docosahexaenoic acid identified in acute coronary syndrome patients with depression. Psychiatry Res, 2006, 141, 279-286.
32. Peet M, Horrobin DF: A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry, 2002, 59, 913-919.
33. Psota TI, Gebauer SK, Kris-Etherton P: Dietary omega-3 fatty acid intake and cardiovascular risk. Am J Cardiol, 2006, 98, 3i-18i.
34. Rozanski A, Blumenthal JA, Davidson KW, Saab PG, Kubzansky L: The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol, 2005, 45, 637-651.
35. Severus WE, Littman AB, Stoll AL: Omega-3 fatty acids, homocysteine, and the increased risk of cardiovascular mortality in major depressive disorder. Harv Rev Psychiatry, 2001, 9, 280-293.
36. Stanley MA, Beck JG, Zebb BJ: Psychometric properties of four anxiety measures in older adults. Behav Res Ther, 1996, 34, 827-838.
37. Tanskanen A, Hibbeln JR, Tuomilehto J, Uutela A, Haukkala A, Viinamaki H, Lehtonen J, Vartiainen E: Fish consumption and depressive symptoms in the general population in Finland. Psychiatr Serv, 2001, 52, 529-531.
38. Task Force for Diagnosis and Treatment of Non-STSegment Elevation Acute Coronary Syndromes of European Society of Cardiology, Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernandez-Aviles F et al.: Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J, 2007, 28, 1598-1660.
39. Taylor VH, Macqueen GM: The role of adipokines in understanding the associations between obesity and depression. J Obes, 2010, 1-6.
40. Thygesen K, Alpert JS, White HD: Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J, 2007, 28, 2525-2538.
41. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G et al.: Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J, 2008, 29, 2909-2945.
42. Watkins LL, Blumenthal JA, Davidson JR, Babyak MA, McCants CB, Sketch MH: Phobic anxiety, depression, and risk of ventricular arrhythmias in patients with coronary heart disease. Psychosom Med, 2006, 68, 651-656.
43. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G et al.: ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death - executive summary. A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J, 2006, 27, 2099-2140.